IFCT-1001 CHIVA trial : A phase II study of carboplatin (Ca) plus pemetrexed (P) followed by P maintenance, as first-line therapy for human immunodeficiency virus (HIV)–associated advanced non-squamous non-small cell lung cancer (NS-NSCLC)

  • Etude concernée: IFCT-1001
  • Auteurs / Authors: Armelle Lavole, Pascale Tomasini, Isabelle Monnet, Lize Kiakouama-Maleka, Xavier Quantin, Laurent Taillade, Hervé Lena, Philippe Fraisse, Henri Janicot, Clarisse Audigier-Valette, Alain Makinson, Alexandra Langlais, Marie Paule Lebitasy, Franck Morin, Jacques Cadranel
  • Journal / Conference: ASCO
  • Année / Year: 2016
  • PMID: Poster
  • Lien vers la publication: https://ascopubs.org/doi/10.1200/JCO.2016.34.15_suppl.9076